glp-1/gip dual agonist The action of tirzepatide on various organs. GLP-1: Review Article: GLP‐1 Receptor Agonists
Description
Archived from the original on 9 July 2025
Last reviewed: May 24, 2026 Last updated: May 24, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
BMI of 35 or Higher Adults with a BMI of 35 or greater may qualify if the medication is prescribed to reduce excess body weight and maintain weight loss alongside ongoing lifestyle changes
GLP-1 + GIP: A Powerful Combination Some newer medications, like tirzepatide, combine GLP-1 with another hormone called GIP (glucose-dependent insulinotropic polypeptide)
Additional information is available on the company website
The compounding industry pushed back, with a trade group filing a lawsuit against the FDA, arguing that the drug was actually still hard to access for patients
